Skip to main content
Signal8

Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company's Crofelemer Development Program for Rare Intestinal Failure Diseases

$JAGXPress releaseJun 12, 2026, 9:00 AM ETRead the release

Jaguar Health announced that CEO Lisa Conte will present at the Life Sciences Virtual Investor Forum on June 24, 2026. The company also reminded investors of two upcoming scientific presentations on crofelemer for pediatric intestinal failure at the ESPGHAN Annual Meeting later that week.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.